GlassScriptPhysician profile
David Michael Clifford
NPI 1255398749
$598.47
in general payments reported to CMS, 2019-2025
9 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2021: $31.26 · 2022: $83.46 · 2023: $17.73 · 2024: $44.97 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $239.17 | 2025 | Barricaid Acd (Annular Closure Device) |
| Horizon Therapeutics Plc | $128.90 | 2019 | |
| Sanara Medtech INC. | $83.46 | 2022 | |
| Medtronic, INC. | $55.25 | 2021-2024 | Mazor X System, Plasmablade(Tm) |
| Fortis Surgical, LLC | $22.34 | 2024 | |
| Arteriocyte Medical Systems, INC. | $19.02 | 2025 | Magellan |
| Biotronik INC. | $17.60 | 2025 | Acticor 7 Vr-T Dx |
| Abbott Laboratories | $16.37 | 2021 | |
| Bone Support INC. | $16.36 | 2025 | Ceramentbone Void Filler, Cerament G |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clifford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.